Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-infected Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics of Lipovirtide in HIV infection; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lipovirtide

Snippet

Sponsor: Shanxi Kangbao Biological Product Co., Ltd. | Conditions: HIV Infections | Phase 1 | Status: COMPLETED